RFG
VIR icon

RFP Financial Group’s Vir Biotechnology VIR Stock Holding History

RFP Financial Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20
Closed -$201 – 953
2023
Q4 		$201 Hold
20
– – ﹤0.01% 860
2023
Q3 		$187 Hold
20
– – ﹤0.01% 883
2023
Q2 		$491 Hold
20
– – ﹤0.01% 894
2023
Q1 		$465 Hold
20
– – ﹤0.01% 710
2022
Q4 		$506 Buy
+20
New +$490 ﹤0.01% 862

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

RFP Financial Group's VIR Position: Q1 2024 in Review

RFP Financial Group sold out of Vir Biotechnology (VIR) in Q1 2024, closing a stake of 20 shares — an estimated $201 sold.

RFP Financial Group first reported a position in VIR in Q4 2022 and held it in 5 quarters. The position peaked at $506 in Q4 2022. 209 funds tracked by Wall St. Rank hold VIR as of Q1 2024.

  • RFP Financial Group reported no remaining Vir Biotechnology position as of Q1 2024 after selling out during the quarter.
  • RFP Financial Group sold 20 Vir Biotechnology shares in Q1 2024, an estimated $201.
  • RFP Financial Group first reported a position in Vir Biotechnology in Q4 2022 and held it in 5 quarters.
  • RFP Financial Group's Vir Biotechnology position peaked at $506 in Q4 2022.
  • 209 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2024.

Based on RFP Financial Group's 13F filing for Q1 2024, filed 9 May 2024.